Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection

Intervirology

Volumn 48, Issue 1, 2005, Pages 10-15

  Kim, Yoon Jun ^a   Lee, Hyo Suk ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Chronic hepatitis B; Genetic association study; Genetic epidemiology; Hepatocellular carcinoma; Single nucleotide polymorphism

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RISK; CHRONIC HEPATITIS; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK PATIENT; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MUTAGENESIS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS VIRULENCE;

CARCINOMA, HEPATOCELLULAR; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 17244382088     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082089     Document Type: Review

References (47)

1. Imyanitov EN, Togo AV, Hanson KP: Searching for cancer-associated gene polymorphisms: Promises and obstacles. Cancer Lett 2004;204:3-14.
2. Ponder BA: Cancer genetics. Nature 2001;411:336-341.
3. Nathanson KL, Wooster R, Weber BL, Nathanson KN: Breast cancer genetics: What we know and what we need. Nat Med 2001;7:552-556.
4. Lander ES, Linton LM, Birren B, et al: Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
5. Venter JC, Adams MD, Myers EW, et al: The sequence of the human genome. Science 2001;291:1304-1351.
6. Risch NJ: Searching for genetic determinants in the new millennium. Nature 2000;405:847-856.
7. Botstein D, Risch N: Discovering genotypes underlying human phenotypes: Past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003;33(suppl):228-237.
8. Kruglyak L, Nickerson DA: Variation is the spice of life. Nat Genet 2001;27:234-236.
9. Carlson CS, Eberle MA, Rieder MJ, Smith JD, Kruglyak L, Nickerson DA: Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat Genet 2003;33:518-521.
10. Risch N: The genetic epidemiology of cancer: Interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2001;10:733-741.
11. Iino S: Natural history of hepatitis B and C virus infections. Oncology 2002;62(suppl 1):18-23.
12. Yu MC, Yuan JM, Govindarajan S, Ross RK: Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 2000;14:703-709.
13. Dickinson JA, Wun YT, Wong SL: Modelling death rates for carriers of hepatitis B. Epidemiol Infect 2002;128:83-92.
14. Brunetto MR, Rodriguez UA, Bonino F: Hepatitis B virus mutants. Intervirology 1999;42:69-80.
15. Koziel MJ: The immunopathogenesis of HBV infection. Antivir Ther 1998;3:13-24.
16. Chisari FV, Ferrari C: Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995;13:29-60.
17. Guidotti LG, Chisari FV: Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001;19:65-91.
18. Abel L, Dessein AJ: The impact of host genetics on susceptibility to human infectious diseases. Curr Opin Immunol 1997;9:509-516.
19. McNicholl J: Host genes and infectious diseases. Emerg Infect Dis 1998;4:423-426.
20. McNicholl JM, Cuenco KT: Host genes and infectious diseases. HIV, other pathogens, and a public health perspective. Am J Prev Med 1999;16:141-154.
21. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D: Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-510.
22. Yu MW, Chang HC, Liaw YF, Lin SM, Lee SD, Liu CJ, Chen PJ, Hsiao TJ, Lee PH, Chen CJ: Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 2000;92:1159-1164.
23. Chen CJ, Yu MW, Liaw YF: Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S294-S308.
24. Erichsen HC, Chanock SJ: SNPs in cancer research and treatment. Br J Cancer 2004;90:747-751.
25. Bosch FX, Ribes J, Borras J: Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271-285.
26. Furberg AH, Ambrosone CB: Molecular epidemiology, biomarkers and cancer prevention. Trends Mol Med 2001;7:517-521.
27. Lee HS, Yoon JH, Kamimura S, Iwata K, Watanabe H, Kim CY: Lack of association of cytochrome P450 2E1 genetic polymorphisms with the risk of human hepatocellular carcinoma. Int J Cancer 1997;71:737-740.
28. Yu MW, Gladek-Yarborough A, Chiamprasert S, Santella RM, Liaw YF, Chen CJ: Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 1995;109:1266-1273.
29. Yu MW, Chiu YH, Yang SY, Santella RM, Chern HD, Liaw YF, Chen CJ: Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Br J Cancer 1999;80:598-603.
30. Yu MW, Chiu YH, Chiang YC, Chen CH, Lee TH, Santella RM, Chern HD, Liaw YF, Chen CJ: Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: Independent and interactive effects. Am J Epidemiol 1999;149:621-629.
31. Tukey RH, Strassburg CP: Human UDP-glucuronosyltransferases: Metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 2000;40:581-616.
32. Vogel A, Kneip S, Barut A, Ehmer U, Tukey RH, Manns MP, Strassburg CP: Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology 2001;121:1136-1144.
33. Ehmer U, Vogel A, Schutte JK, Krone B, Manns MP, Strassburg CP: Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 2004;39:970-977.
34. Yu MW, Pai CI, Yang SY, Hsiao TJ, Chang HC, Lin SM, Liaw YF, Chen PJ, Chen CJ: Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: Impact of smoking on risk. Gut 2000;47:703-709.
35. Yu MW, Yang SY, Pan IJ, Lin CL, Liu CJ, Liaw YF, Lin SM, Chen PJ, Lee SD, Chen CJ: Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 2003;95:1485-1488.
36. Sheen IS, Jeng KS, Wu JY: Is p53 gene mutation an indicatior of the biological behaviors of recurrence of hepatocellular carcinoma? World J Gastroenterol 2003;9:1202-1207.
37. Lin J, Zhu MH, Zhu S, Qu JH, Li FM, Ni CR: The role of hepatitis B virus X gene and p53 on hepatocellular carcinoma cell growth. Zhonghua Bing Li Xue Za Zhi 2003;32:43-47.
38. Ding X, Park YN, Taltavull TC, Thung SN, Jin X, Jin Y, Trung NS, Edamoto Y, Sata T, Abe K: Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: Comparison among six different countries. Jpn J Infect Dis 2003;56:12-18.
39. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ: A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 1999;29:697-702.
40. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A, Akhurst RJ: TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996;86:531-542.
41. Pasche B, Kolachana P, Nafa K, Satagopan J, Chen YG, Lo RS, Brener D, Yang D, Kirstein L, Oddoux C, Ostrer H, Vineis P, Varesco L, Jhanwar S, Luzzatto L, Massague J, Offit K: TbetaR-I(6A) is a candidate tumor susceptibility allele. Cancer Res 1999;59:5678-5682.
42. Tang B, Bottinger EP, Jakowlew SB, Bagnall KM, Mariano J, Anver MR, Letterio JJ, Wakefield LM: Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. Nat Med 1998;4:802-807.
43. Ziv E, Cauley J, Morin PA, Saiz R, Browner WS: Association between the T29→C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures. JAMA 2001;285:2859-2863.
44. Kim YJ, Lee HS, Im JP, Min BH, Kim HD, Jeong JB, Yoon JH, Kim CY, Kim MS, Kim JY, Jung JH, Kim LH, Park BL, Shin HD: Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 2003;35:196-202.
45. Redpath S, Ghazal P, Gascoigne NR: Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol 2001;9:86-92.
46. Shin HD, Winkler C, Stephens JC, Bream J, Young H, Goedert JJ, O'Brien TR, Vlahov D, Buchbinder S, Giorgi J, Rinaldo C, Donfield S, Willoughby A, O'Brien SJ, Smith MW: Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL-10. Proc Natl Acad Sci USA 2000;97:14467-14472.
47. Shin HD, Park BL, Kim LH, Jung JH, Kim JY, Yoon JH, Kim YJ, Lee HS: Interleukin-10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 2003; 12:901-906.